申请人:Rhone-Poulenc Sante
公开号:US05223529A1
公开(公告)日:1993-06-29
Compounds of formula: ##STR1## in which R.sub.1 is (a) a phenyl radical or a substituted phenyl radical, (b) a chain --CH(R.sub.8)--COOR.sub.4, (c) a chain --CH.sub.2 --CO--NR.sub.5 R.sub.6 or (d) a phenylalkyl radical, R.sub.2 is a methylene or ethylene radical or a radical --CH(R.sub.7)--, R.sub.3 is a 1- or 2-naphthyl radical, 2- or 3-indolyl or phenylamino radical in which the phenyl ring is optionally substituted on the understanding that, when R.sub.3 is 1- or 2-naphthyl or 2- or 3-indolyl radical, R.sub.7 cannot represent a benzyl, alkylthioalkyl or phenyl radical, as well as, when R.sub.2 is a radical --CH(R.sub.7)--, their racemates and their stereoisomers, and medicinal products containing them.
式为##STR1##的化合物,其中R.sub.1是(a)苯基或取代苯基,(b)链--CH(R.sub.8)--COOR.sub.4,(c)链--CH.sub.2--CO--NR.sub.5 R.sub.6或(d)苯基烷基基团,R.sub.2是亚甲基或乙烯基或基团--CH(R.sub.7)--,R.sub.3是1-或2-萘基基团,2-或3-吲哚基或苯基氨基基团,其中苯环可选地取代,当R.sub.3是1-或2-萘基或2-或3-吲哚基团时,R.sub.7不能表示苄基、烷基硫代烷基或苯基基团,以及当R.sub.2是基团--CH(R.sub.7)--时,它们的外消旋体和立体异构体,以及含有它们的药物制剂。